Published in EMBO Rep on April 08, 2011
Integrated molecular analysis of adult T cell leukemia/lymphoma. Nat Genet (2015) 2.44
Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers. J Pathol (2011) 2.27
The Capicua repressor--a general sensor of RTK signaling in development and disease. J Cell Sci (2012) 1.29
Candidate genes and functional noncoding variants identified in a canine model of obsessive-compulsive disorder. Genome Biol (2014) 1.04
Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias. Cerebellum (2014) 1.03
Analysis of copy number variation in Alzheimer's disease: the NIALOAD/ NCRAD Family Study. Curr Alzheimer Res (2012) 0.97
The vasculome of the mouse brain. PLoS One (2012) 0.89
Mouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II. Mol Neurobiol (2012) 0.86
The transcriptional corepressor SMRTER influences both Notch and ecdysone signaling during Drosophila development. Biol Open (2011) 0.84
Drosophila as an In Vivo Model for Human Neurodegenerative Disease. Genetics (2015) 0.83
An out-of-frame overlapping reading frame in the ataxin-1 coding sequence encodes a novel ataxin-1 interacting protein. J Biol Chem (2013) 0.82
The expanding role for chromatin and transcription in polyglutamine disease. Curr Opin Genet Dev (2014) 0.81
The importance of serine 776 in Ataxin-1 partner selection: a FRET analysis. Sci Rep (2012) 0.80
Haploinsufficiency of two histone modifier genes on 6p22.3, ATXN1 and JARID2, is associated with intellectual disability. Orphanet J Rare Dis (2013) 0.80
Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide. Mol Cancer (2015) 0.79
Kaleidoscopic protein-protein interactions in the life and death of ataxin-1: new strategies against protein aggregation. Trends Neurosci (2014) 0.78
ATXN1L, CIC, and ETS Transcription Factors Modulate Sensitivity to MAPK Pathway Inhibition. Cell Rep (2017) 0.78
Analysis of hippocampal gene expression profile of Alzheimer's disease model rats using genome chip bioinformatics. Neural Regen Res (2012) 0.75
Ataxin 2-binding protein 1 is a context-specific positive regulator of Notch signaling during neurogenesis in Drosophila melanogaster. Development (2017) 0.75
Molecular Programming of Tumor-Infiltrating CD8+ T Cells and IL15 Resistance. Cancer Immunol Res (2016) 0.75
Large-Scale Functional RNAi Screen in C. elegans Identifies TGF-β and Notch Signaling Pathways as Modifiers of CACNA1A. ASN Neuro (2016) 0.75
Ataxin-1 regulates epithelial-mesenchymal transition of cervical cancer cells. Oncotarget (2017) 0.75
The canonical Notch signaling pathway: unfolding the activation mechanism. Cell (2009) 14.72
Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol (2006) 13.12
Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature (1998) 10.58
Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet (1993) 7.97
Notch signaling: control of cell communication and cell fate. Development (2004) 5.95
A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. Genes Dev (1998) 4.78
Identification of genes that modify ataxin-1-induced neurodegeneration. Nature (2000) 4.02
The intracellular domain of mouse Notch: a constitutively activated repressor of myogenesis directed at the basic helix-loop-helix region of MyoD. Development (1994) 3.99
MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. Nat Genet (2000) 3.82
ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Cell (2006) 3.39
Suppressor of Hairless, the Drosophila homolog of the mouse recombination signal-binding protein gene, controls sensory organ cell fates. Cell (1992) 2.95
Delta-induced Notch signaling mediated by RBP-J inhibits MyoD expression and myogenesis. J Biol Chem (1999) 2.65
A protein binding to the J kappa recombination sequence of immunoglobulin genes contains a sequence related to the integrase motif. Nature (1990) 2.29
Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nat Genet (1994) 2.13
Comparative analysis of the human and mouse Hey1 promoter: Hey genes are new Notch target genes. Biochem Biophys Res Commun (2000) 2.06
The Drosophila homolog of the immunoglobulin recombination signal-binding protein regulates peripheral nervous system development. Cell (1992) 1.96
Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1. J Biol Chem (2008) 1.92
HERP, a new primary target of Notch regulated by ligand binding. Mol Cell Biol (2001) 1.85
Notch signaling: the demise of elegant simplicity. Curr Opin Genet Dev (2004) 1.79
TBL1 and TBLR1 phosphorylation on regulated gene promoters overcomes dual CtBP and NCoR/SMRT transcriptional repression checkpoints. Mol Cell (2008) 1.65
Polyglutamine neurodegenerative diseases and regulation of transcription: assembling the puzzle. Genes Dev (2006) 1.65
Notch and presenilin regulate cellular expansion and cytokine secretion but cannot instruct Th1/Th2 fate acquisition. PLoS One (2008) 1.56
Pattern formation in the Drosophila wing: The development of the veins. Bioessays (2003) 1.51
Ataxin 1, a SCA1 neurodegenerative disorder protein, is functionally linked to the silencing mediator of retinoid and thyroid hormone receptors. Proc Natl Acad Sci U S A (2004) 1.47
Mice lacking ataxin-1 display learning deficits and decreased hippocampal paired-pulse facilitation. J Neurosci (1998) 1.46
Partial loss of ataxin-1 function contributes to transcriptional dysregulation in spinocerebellar ataxia type 1 pathogenesis. PLoS Genet (2010) 1.42
Inhibition of myogenesis by Notch: evidence for multiple pathways. J Cell Physiol (2009) 1.28
Boat, an AXH domain protein, suppresses the cytotoxicity of mutant ataxin-1. EMBO J (2005) 1.25
The role of LANP and ataxin 1 in E4F-mediated transcriptional repression. EMBO Rep (2007) 1.07
The neurodegenerative disease protein ataxin-1 antagonizes the neuronal survival function of myocyte enhancer factor-2. J Biol Chem (2007) 1.07
Loss of function of ATXN1 increases amyloid beta-protein levels by potentiating beta-secretase processing of beta-amyloid precursor protein. J Biol Chem (2010) 1.01
NAADP mobilizes calcium from acidic organelles through two-pore channels. Nature (2009) 4.41
Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J (2003) 3.72
Cancer survival in China, 2003-2005: a population-based study. Int J Cancer (2014) 3.32
MG53 nucleates assembly of cell membrane repair machinery. Nat Cell Biol (2008) 3.24
Uncontrolled calcium sparks act as a dystrophic signal for mammalian skeletal muscle. Nat Cell Biol (2005) 3.14
MG53 constitutes a primary determinant of cardiac ischemic preconditioning. Circulation (2010) 2.35
Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy. Sci Transl Med (2012) 2.27
A unified nomenclature for protein subunits of mediator complexes linking transcriptional regulators to RNA polymerase II. Mol Cell (2004) 2.27
Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin. J Biol Chem (2009) 2.25
Dysfunction of store-operated calcium channel in muscle cells lacking mg29. Nat Cell Biol (2002) 2.03
Ordered recruitment of histone acetyltransferases and the TRAP/Mediator complex to thyroid hormone-responsive promoters in vivo. Proc Natl Acad Sci U S A (2002) 1.93
Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates. Proc Natl Acad Sci U S A (2003) 1.82
Cardioprotection of ischemia/reperfusion injury by cholesterol-dependent MG53-mediated membrane repair. Circ Res (2010) 1.74
Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res (2005) 1.72
Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans. J Mol Cell Cardiol (2007) 1.70
A coregulatory role for the TRAP-mediator complex in androgen receptor-mediated gene expression. J Biol Chem (2002) 1.66
Muscle aging is associated with compromised Ca2+ spark signaling and segregated intracellular Ca2+ release. J Cell Biol (2006) 1.64
Natural selection and population history in the human angiotensinogen gene (AGT): 736 complete AGT sequences in chromosomes from around the world. Am J Hum Genet (2004) 1.61
MG53 regulates membrane budding and exocytosis in muscle cells. J Biol Chem (2008) 1.60
TRIC channels are essential for Ca2+ handling in intracellular stores. Nature (2007) 1.58
Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers. J Clin Invest (2011) 1.54
A versatile single-plasmid system for tissue-specific and inducible control of gene expression in transgenic mice. FASEB J (2011) 1.51
Uncoupling store-operated Ca2+ entry and altered Ca2+ release from sarcoplasmic reticulum through silencing of junctophilin genes. Biophys J (2006) 1.48
Extreme mtDNA homogeneity in continental Asian populations. Am J Phys Anthropol (2002) 1.47
Azumolene inhibits a component of store-operated calcium entry coupled to the skeletal muscle ryanodine receptor. J Biol Chem (2006) 1.46
Enhanced resistance to fatigue and altered calcium handling properties of sarcalumenin knockout mice. Physiol Genomics (2005) 1.43
Polymerase transcriptase release factor (PTRF) anchors MG53 protein to cell injury site for initiation of membrane repair. J Biol Chem (2011) 1.40
Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2. Mol Cancer Ther (2006) 1.39
Histone deacetylase-associating Atrophin proteins are nuclear receptor corepressors. Genes Dev (2006) 1.38
Organic anion transporter OAT1 undergoes constitutive and protein kinase C-regulated trafficking through a dynamin- and clathrin-dependent pathway. J Biol Chem (2008) 1.34
Identification of a dantrolene-binding sequence on the skeletal muscle ryanodine receptor. J Biol Chem (2002) 1.34
Imaging superoxide flash and metabolism-coupled mitochondrial permeability transition in living animals. Cell Res (2011) 1.32
Negatively charged amino acids within the intraluminal loop of ryanodine receptor are involved in the interaction with triadin. J Biol Chem (2003) 1.32
Junctophilin-2 expression silencing causes cardiocyte hypertrophy and abnormal intracellular calcium-handling. Circ Heart Fail (2011) 1.32
Repression of androgen receptor mediated transcription by the ErbB-3 binding protein, Ebp1. Oncogene (2002) 1.28
A retrograde signal from calsequestrin for the regulation of store-operated Ca2+ entry in skeletal muscle. J Biol Chem (2002) 1.28
Calcium signaling via two-pore channels: local or global, that is the question. Am J Physiol Cell Physiol (2009) 1.26
Substituent group variations directing the molecular packing, electronic structure, and aggregation-induced emission property of isophorone derivatives. J Org Chem (2013) 1.26
TPCs: Endolysosomal channels for Ca2+ mobilization from acidic organelles triggered by NAADP. FEBS Lett (2010) 1.26
Conformation-dependent stability of junctophilin 1 (JP1) and ryanodine receptor type 1 (RyR1) channel complex is mediated by their hyper-reactive thiols. J Biol Chem (2007) 1.25
Boat, an AXH domain protein, suppresses the cytotoxicity of mutant ataxin-1. EMBO J (2005) 1.25
Atrophin recruits HDAC1/2 and G9a to modify histone H3K9 and to determine cell fates. EMBO Rep (2008) 1.25
A case-control study of reproductive factors associated with subtypes of breast cancer in Northeast China. Med Oncol (2009) 1.25
Monoclonal antibodies: what are the pharmacokinetic and pharmacodynamic considerations for drug development? Expert Opin Drug Metab Toxicol (2012) 1.25
A rapid and efficient PCR-based mutagenesis method applicable to cell physiology study. Am J Physiol Cell Physiol (2005) 1.24
Y-chromosomal DNA haplogroups and their implications for the dual origins of the Koreans. Hum Genet (2003) 1.24
Immuno-proteomic approach to excitation--contraction coupling in skeletal and cardiac muscle: molecular insights revealed by the mitsugumins. Cell Calcium (2007) 1.24
Compromised store-operated Ca2+ entry in aged skeletal muscle. Aging Cell (2008) 1.23
The role of N-linked glycosylation in protein folding, membrane targeting, and substrate binding of human organic anion transporter hOAT4. Mol Pharmacol (2004) 1.22
Dysferlin, annexin A1, and mitsugumin 53 are upregulated in muscular dystrophy and localize to longitudinal tubules of the T-system with stretch. J Neuropathol Exp Neurol (2011) 1.21
Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors. BMC Cancer (2010) 1.20
The acid test: the discovery of two-pore channels (TPCs) as NAADP-gated endolysosomal Ca(2+) release channels. Pflugers Arch (2009) 1.19
MED1 phosphorylation promotes its association with mediator: implications for nuclear receptor signaling. Mol Cell Biol (2008) 1.18
Cyclin-dependent kinase 8 positively cooperates with Mediator to promote thyroid hormone receptor-dependent transcriptional activation. Mol Cell Biol (2010) 1.18
MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling. Nat Commun (2013) 1.16
Nonmuscle myosin IIA facilitates vesicle trafficking for MG53-mediated cell membrane repair. FASEB J (2012) 1.16
Probing a putative dantrolene-binding site on the cardiac ryanodine receptor. Biochem J (2005) 1.15
Activation of TRAP/mediator subunit TRAP220/Med1 is regulated by mitogen-activated protein kinase-dependent phosphorylation. Mol Cell Biol (2005) 1.13
Enhancing muscle membrane repair by gene delivery of MG53 ameliorates muscular dystrophy and heart failure in δ-Sarcoglycan-deficient hamsters. Mol Ther (2012) 1.13
CDK inhibitor p57 (Kip2) is negatively regulated by COP9 signalosome subunit 6. Cell Cycle (2012) 1.12
Clinical implications of stem cell gene Oct-4 expression in breast cancer. Ann Surg (2011) 1.10
Atrophin proteins: an overview of a new class of nuclear receptor corepressors. Nucl Recept Signal (2008) 1.10
Clinical implications for nestin protein expression in breast cancer. Cancer Sci (2009) 1.10
MG53 participates in ischaemic postconditioning through the RISK signalling pathway. Cardiovasc Res (2011) 1.09
Nuclear receptor recruitment of histone-modifying enzymes to target gene promoters. Vitam Horm (2004) 1.09
Mitsugumin 53 (MG53) facilitates vesicle trafficking in striated muscle to contribute to cell membrane repair. Commun Integr Biol (2009) 1.08
Butylated hydroxyanisole regulates ARE-mediated gene expression via Nrf2 coupled with ERK and JNK signaling pathway in HepG2 cells. Mol Carcinog (2006) 1.07
Girdin protein: a new potential distant metastasis predictor of breast cancer. Med Oncol (2011) 1.07
The neurodegenerative disease protein ataxin-1 antagonizes the neuronal survival function of myocyte enhancer factor-2. J Biol Chem (2007) 1.07
Nuclear translocation of cytochrome c during apoptosis. J Biol Chem (2004) 1.06
Cyclic adenosine diphosphate ribose activates ryanodine receptors, whereas NAADP activates two-pore domain channels. J Biol Chem (2011) 1.06
Prox1 regulates a transitory state for interneuron neurogenesis in the spinal cord. Dev Dyn (2008) 1.05
Increased store-operated Ca2+ entry in skeletal muscle with reduced calsequestrin-1 expression. Biophys J (2010) 1.05
Targeting of protein kinase A by muscle A kinase-anchoring protein (mAKAP) regulates phosphorylation and function of the skeletal muscle ryanodine receptor. J Biol Chem (2003) 1.05
Prognostic role of lymphatic vessel invasion in early gastric cancer: a retrospective study of 188 cases. Surg Oncol (2008) 1.04
Thyroid hormone-regulated target genes have distinct patterns of coactivator recruitment and histone acetylation. Mol Endocrinol (2005) 1.04
Insulators target active genes to transcription factories and polycomb-repressed genes to polycomb bodies. PLoS Genet (2013) 1.03
Mutations in NR2E3 can cause dominant or recessive retinal degenerations in the same family. Hum Mutat (2009) 1.03
S165F mutation of junctophilin 2 affects Ca2+ signalling in skeletal muscle. Biochem J (2010) 1.02
Redox-dependent oligomerization through a leucine zipper motif is essential for MG53-mediated cell membrane repair. Am J Physiol Cell Physiol (2011) 1.02
Mitochondrial calcium uptake regulates rapid calcium transients in skeletal muscle during excitation-contraction (E-C) coupling. J Biol Chem (2011) 1.00
N-butanol Extract from Melilotus Suaveolens Ledeb Affects Pro- and Anti-Inflammatory Cytokines and Mediators. Evid Based Complement Alternat Med (2007) 0.99
Regulation of Aurora-A kinase gene expression via GABP recruitment of TRAP220/MED1. J Biol Chem (2006) 0.99
Disrupted membrane structure and intracellular Ca²⁺ signaling in adult skeletal muscle with acute knockdown of Bin1. PLoS One (2011) 0.99
Preliminary exploration on anti-inflammatory mechanism of Corilagin (beta-1-O-galloyl-3,6-(R)-hexahydroxydiphenoyl-D-glucose) in vitro. Int Immunopharmacol (2008) 0.99
Charade of the SR K+-channel: two ion-channels, TRIC-A and TRIC-B, masquerade as a single K+-channel. Biophys J (2010) 0.99
Inner anti-inflammatory mechanisms of petroleum ether extract from Melilotus suaveolens Ledeb. Inflammation (2007) 0.99
Calcium-dependent facilitation and graded deactivation of store-operated calcium entry in fetal skeletal muscle. Biophys J (2004) 0.98
Expression of CD133, PAX2, ESA, and GPR30 in invasive ductal breast carcinomas. Chin Med J (Engl) (2009) 0.98
An open-label, single-dose bioavailability study of the pharmacokinetics of CAT-354 after subcutaneous and intravenous administration in healthy males. Br J Clin Pharmacol (2010) 0.97
Store-operated Ca(2+) entry (SOCE) contributes to normal skeletal muscle contractility in young but not in aged skeletal muscle. Aging (Albany NY) (2011) 0.97